Research work · 2017

Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study

Michael James Overman, Ray McDermott, Joseph L. Leach

The Lancet Oncology

Read free full text

DOI: 10.1016/s1470-2045(17)30422-9